BRIEF published on 08/24/2026 at 18:47, 2 months 20 days ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 2 months 20 days ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
PRESS RELEASE published on 08/24/2026 at 18:42, 2 months 20 days ago Informations privilégiées: Autres communiqués Aliko Scientific publie des informations financières complémentaires suite à la publication de ses résultats annuels 2025, réaffirmant sa dynamique d'activité et sa situation financière renforcée Résultats Annuels Trésorerie Situation Financière ALIKO SCIENTIFIC Dynamique D'activité
BRIEF published on 07/30/2026 at 21:54, 3 months 13 days ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
BRIEF published on 07/30/2026 at 21:54, 3 months 13 days ago Ikonisys SA annonce des résultats annuels 2025 prometteurs Résultats Financiers Croissance Ikonisys Diagnostic Oncologique ALIKO SCIENTIFIC
BRIEF published on 07/30/2026 at 21:54, 3 months 13 days ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 3 months 13 days ago Ikonisys SA annonce une augmentation de son chiffre d'affaires et des développements en 2025 Ikonisys SA Croissance Des Revenus Résultats Financiers 2025 Diagnostic En Oncologie Aliko Scientifique
PRESS RELEASE published on 07/30/2026 at 21:49, 3 months 13 days ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
PRESS RELEASE published on 07/30/2026 at 21:49, 3 months 13 days ago Informations privilégiées / Communiqué sur comptes, résultats Ikonisys SA publie ses résultats financiers annuels 2025. Amélioration de 32,9% de l'EBITDA à -1,14 M€. Développement de la plateforme oncologique avec brevet ACTA, Urine24 et accord Menarini Diagnostics Résultats Financiers EBITDA Ikonisys SA Développements Plateforme Oncologique
BRIEF published on 07/23/2026 at 07:35, 3 months 21 days ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
Published on 11/13/2026 at 18:30, 1 hour 3 minutes ago Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario
Published on 11/13/2026 at 18:05, 1 hour 28 minutes ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
Published on 11/13/2026 at 17:25, 2 hours 8 minutes ago Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
Published on 11/13/2026 at 15:40, 3 hours 53 minutes ago Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
Published on 11/13/2026 at 19:08, 24 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 33 minutes ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 18:04, 1 hour 29 minutes ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Published on 11/13/2026 at 11:35, 7 hours 58 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 7 hours 58 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 11 hours 33 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 20 hours 20 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
